Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Pharmaceuticals Market

PRODUCT TITLE PUBLISHED
New castle disease New castle disease
New castle disease and Infectious Bronchitis, Gumboro...
Upcoming
Porcine parvovirus Porcine parvovirus
Porcine parvovirus and Porcine Circovirus II, Swine...
Upcoming
Porcine Circovirus II Porcine Circovirus II
Porcine Circovirus II and Porcine parvovirus, Swine Influenza,...
Upcoming
Swine Influenza Swine Influenza
Swine Influenza and Porcine parvovirus, Porcine Circovirus...
Upcoming
Swine pneumonia Swine pneumonia
Swine pneumonia and Porcine parvovirus, Porcine Circovirus...
Upcoming
Porcine Reproductive Respiratory Syndrome (PRRS) Porcine Reproductive Respiratory Syndrome (PRRS)
Porcine Reproductive Respiratory Syndrome (PRRS) and Porcine parvovirus,
Upcoming
Equine Encephalomyelitis Equine Encephalomyelitis
Equine Encephalomyelitis and Strangles, Equine Influenza,
Upcoming
Strangles Strangles
Strangles and Equine Encephalomyelitis, Equine...
Upcoming
Equine Influenza Equine Influenza
Equine Influenza and Equine Encephalomyelitis, Strangles,
Upcoming
Equine Rhinopneumonitis Equine Rhinopneumonitis
Equine Rhinopneumonitis and Equine Encephalomyelitis,
Upcoming
Vibriosis Vibriosis
Vibriosis and Pasteurellosis, Furunculosis and
Upcoming
Pasteurellosis Pasteurellosis
Pasteurellosis and Vibriosis, Furunculosis and
Upcoming
Furunculosis Furunculosis
Furunculosis and Vibriosis, Pasteurellosis and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Anti-Androgens Anti-Androgens
Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Phase III (Immunotherapy) Phase III (Immunotherapy)
Phase III (Immunotherapy) and Phase I (Immunotherapy) and
Upcoming
Phase III (Targeted Therapy) Phase III (Targeted Therapy)
Phase III (Targeted Therapy) and Phase I (Targeted Therapy) and
Upcoming
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy)
Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and
Upcoming
North America Live attenuated vaccines North America Live attenuated vaccines
The North American Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $805 million in 2013 and expected to be $999 million by 2018 at a CAGR of 4.4%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
812 reports | Show
Connect With Us
US/CAN : +1-888-502-0539